Online Trauma Training
Bookmark and Share

Pharmacological Strategies for Trauma-Related Mental Health Complaints (Master Clinician Video, 1.5 Credits)

with Thomas Mellman, MD

Buy with CE Credit
Buy without CE Credit 

Accumulation of findings implicating neurobiological dysregulations as well as overlapping features and frequent comorbidity with disorders that respond to pharmacotherapy have spurred interest in medication treatment for post-traumatic stress disorder (PTSD). While two medications from the selective serotonin reuptake inhibitor class have U.S. Food & Drug Administration approval for PTSD, there remains controversy regarding their overall efficacy and population specificity. Other classes of medications are widely applied to PTSD treatment with mixed evidence bases. Medications have also been applied to symptom specific targets (most notably prazosin for sleep disturbance), acute intervention for preventing PTSD, and enhancing cognitive behavioral therapy. Dr. Mellman brings experience in clinical trials, published syntheses and interpretations of the research evidence, and most notably, treating patients from both veteran and civilian settings. He will present relevant clinical pharmacology, review of research studies, and respond to questions and facilitate discussion regarding clinical scenarios involving medication treatment (and consideration of prescribing) and PTSD. The session will accommodate the interests of prescribing and non-prescribing clinicians.

Learning Objectives

  • Cite current literature on pharmacological aid for mental health conditions.
  • Explore the countraindications and side effects of the most popular pharmacological agents used with this population.
  • Practice with a review of case examples.